Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of botulinum toxin type A injection for crow's feet lines in China
CTR20140535Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in lateral canthal rhytides, sponsored by AbbVie Inc.. Started Aug 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
lateral canthal rhytides
Beyond the preview
Go deeper on CTR20140535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140535.